The future of pemvidutide (and by extension Altimmune) rests on future trials showing weight reductions that match Wegovy or replicating NASH improvement trends from the Phase 1b (no small feat)
Tirzepatide: GIP and GLP-1 provide complementary incretin effects on insulin secretion, appetite regulation, and glucose homeostasis
With compounded semaglutide, dosages and titration schedules are also carefully determined by your healthcare provider
Electrolytes matter here too
Data quality metrics analyzed included completion rates, dropouts, consent rates, duplicate records, bot detection, speeders, response consistency, missing data, outliers, and quota achievement